FDA Greenlights Kythera’s Kybella
In a much anticipated approval, the FDA has given its nod to Kythera's Kybella to treat double chins.
In a much anticipated approval, the FDA has given its nod to Kythera's Kybella to treat double chins.
The AAFPRS 2025 Annual Survey reports a 19 percent increase in facial procedures, with patients favoring earlier, subtle interventions, rising male participation, and increased demand linked to weight loss medications and menopause.